Novartis Lawsuit Accuses Amgen Of Trying To Welsh On Migraine DealInvestors Business Daily • 04/04/19
The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis EarningsBenzinga • 04/03/19
3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab FlopThe Motley Fool • 03/30/19
Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug ApprovalsZacks Investment Research • 03/29/19
The Hits Just Keep Coming For Biogen As Rival Novartis Gains MS Drug ApprovalInvestors Business Daily • 03/27/19